In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist

Solid rationales are still present for the identification of synthetic ligands to simultaneously target multiple PPAR subtypes for the treatment of T2DM. The purpose of this study was to characterize the in vitro and in vivo differential effects of chiglitazar, a non-TZD type of PPAR pan-agonist cur...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: He, B. K., Ning, Z. Q., Li, Z. B., Shan, S., Pan, D. S., Ko, B. C. B., Li, P. P., Shen, Z. F., Dou, G. F., Zhang, B. L., Lu, X. P., Gao, Y.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486420/
https://ncbi.nlm.nih.gov/pubmed/23150725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/546548
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires